# Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia

> **NCT05524077** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Western Sydney Local Health District** · enrollment: 162 (estimated)

## Conditions studied

- Heart Disease Structural Disorder
- Ventricular Tachycardia
- Cardiomyopathy, Dilated
- Sarcoidosis
- Cardiomyopathy, Hypertrophic
- Cardiomyopathy Ischemic
- Cardiomyopathy, Familial
- Arrhythmogenic Right Ventricular Cardiomyopathy 1
- Arrhythmogenic Left Ventricular Cardiomyopathy

## Interventions

- **PROCEDURE:** Ablation
- **DRUG:** Anti-arrhythmic Drugs (AADs)

## Key facts

- **NCT ID:** NCT05524077
- **Lead sponsor:** Western Sydney Local Health District
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-07-08
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05524077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05524077, "Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05524077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*